Currently published studies have suggested a crucial role of TLRs/NF-κB signaling transduction in the development of some autoimmune diseases including RA, Sjogren's syndrome and systemic sclerosis [30–32], supporting multiple promising therapeutic targets for these diseases. The gene discussed is NFKB1; the disease is systemic sclerosis.